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Purpose: Occult macular dystrophy (OMD) is a hereditary retinal disease characterized by a 
normal fundus, normal full-field electroretinograms (ERGs), progressive decrease of visual acu-
ity, and abnormal focal macular ERGs. The purpose of this study was to report pattern-reversal 
visual-evoked potential (pVEPs) findings in OMD patients.
Patients and method: The pVEPs recorded from four patients with OMD (aged 42–61 years; 
2 men and 2 women) were reviewed. The visual acuities ranged from 20/200 to 20/30. The 
amplitudes of the N-75 and P-100 (P2 amplitude) and the latency of the N-75 components   
(N1 latency) were analyzed.
Results: The mean (±SD) P2 amplitude was 2.7 ± 1.9 µV for the 5′, 4.8 ± 2.9 µV for the 10′, 
3.2 ± 2.1 µV for the 20′, and 4.4 ± 3.5 µV for the 40′ checkerboard stimuli. The N1 latency 
was 122.2 ± 6.4 ms for the 5′, 105.0 ± 11.5 ms for the 10′, 97.7 ± 10.0 ms for the 20′, and 
91.0 ± 13.7 ms for the 40′ checkerboard stimuli. The mean P2 amplitude was reduced and the 
N1 latency was delayed in comparison with the laboratory standard for the Keio University 
Hospital.
Conclusions: The delayed latency and reduced amplitude suggest a major contribution of the 
central cone pathway to the pVEPs.
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Introduction
Occult macular dystrophy (OMD) is a hereditary macular dystrophy characterized by 
a progressive decrease of the visual acuity, normal fundus, and normal fluorescein 
angiograms.1,2 The hereditary form is an autosomal dominant trait, and recently the 
response gene was identified with mutation in RP1L1.3
The cone and rod components of the full-field electroretinograms (ERGs) are 
  normal, but the focal macular ERGs are reduced. A reduction of the visual acuity 
  without visible fundus abnormalities, and the presence of a central scotoma and/or 
reduced central fusion flicker frequency4 are often seen, and the patients can be 
  misdiagnosed with amblyopia, optic nerve disease, or a nonorganic visual disorder.4 
Only limited information is available on the visual-evoked potentials (VEPs) in patients 
with OMD.5 How the VEPs are affected in this disease with central cone dysfunction 
has not been fully determined. Thus, the purpose of this study was to evaluate the 
pattern-reversal VEPs (pVEPs) in patients with OMD.Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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Subjects and methods
subjects
Four patients diagnosed with OMD at the Keio University 
Hospital between 2000 and 2002 were studied; two were 
men and two were women aged 42, 49, 60, and 69 years, 
respectively (Table 1).
stimulus and recording  
of pattern-reversal VePs
The visual stimulus was a black-and-white pattern check-
erboard generated on a CRT (cathode ray tube)   monitor 
(20-inch, high-resolution display; Ikegami Tsushinki Co, 
Ltd, Tokyo, Japan). The mean luminance was kept at 
109.5 cd/m2, and each check was either white (154 cd/m2) or 
black (65 cd/m2) with a 40.6% contrast. Four check sizes were 
used: 5, 10, 20, and 40 min of arc at an observation distance 
of 150 cm. The amplitude of N-75 and P-100 (P2 amplitude) 
and the latency of the N-75 (N1 latency) were analyzed.
Patients were preadapted to the room lighting, and all 
recordings were performed under dim room lights with 
an illumination of about 50 cd/m2. A small black fixation 
point was present in the center of the stimulus display, 
and the subjects were instructed to fixate the point or the 
center of the screen and to try not to blink. The subjects 
wore their best refractive correction, and all recordings 
were monocular.
The recording electrode was placed 2.0 cm superior to the 
inion, and the reference electrode was placed on one earlobe. 
The ground electrode was placed on the other earlobe.
Signals were amplified 50,000 times with an amplifier 
(VC-11; Nihon Kohden, Tokyo, Japan) and filtered with 
a band-pass filter from 0.5 to 30 Hz. Sixty-four responses 
were averaged.
Normative data were collected from 40 age-matched 
patients who did not have any ocular diseases except 
for refractive errors (age range 40–67 years; average 
53.1 ± 8.41 years).
All of the procedures conformed to the guidelines of 
the Declaration of Helsinki, and an informed consent was 
obtained from all subjects after an explanation of the purpose 
and the procedures to be used in the experiments.
Results
Patients were diagnosed with OMD by the following findings 
in both eyes: progressive decrease in the visual acuity, normal 
fundus, normal fluorescein angiograms, central scotoma in 
Goldman perimetry, normal cone and rod components of the 
full-field ERGs, and abnormal focal macular or multifocal 
ERGs (mfERGs). Their visual acuities ranged from 20/200 to 
20/30. None had a history of ophthalmological abnormalities, 
such as glaucoma or diabetic retinopathy that could affect 
the visual function especially the pVEPs.
All cases had at least one individual in their pedigree 
who was also diagnosed with OMD. Case 4 was a second 
cousin of case 2 (Table 1). The interval between the onset of 
the decreased visual acuity and diagnosis at our clinic was 
1–25 years. Three of the cases were genetically diagnosed 
with OMD.
VeP results
A plot of the P2 amplitudes as a function of pattern check 
size in the four patients with OMD is shown in Figure 1A. 
In three of the cases, the amplitudes of P2 were smaller 
Table 1 Clinical characteristics of the patients and the result of the examinations
Patient Age and 
gender
Family 
history
BCVA  Visual  
field
Fundus 
appearance
Fluorescein 
angiography
Full field 
ERG
Multifocal 
ERG
Genetic 
diagnosis
OD OS
1 42, Female + 20/200 20/200 Central  
scotoma
normal normal normal Decreased 
amplitude in 
fovea
Mutation in 
RP1L1
2 61, Female + 20/200 20/200 Central  
scotoma
normal normal normal Decreased 
amplitude in 
fovea
Mutation in 
RP1L1
3 60, Male + 20/60 20/200 Central  
scotoma
normal normal normal Decreased 
amplitude in 
fovea
Mutation in 
RP1L1
4 49, Male + 20/30 20/30 Central  
scotoma
normal normal normal Decreased 
amplitude in 
fovea
not 
examined
Notes: Case 4 is a second cousin of case 2. Focal macular electroretinograms (ergs) were recorded in patients 1. Multifocal ergs were recorded from all the patients.
Abbreviations: BCVA, best-corrected visual acuity; OD, right eye; Os, left eye.Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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than that of the normal controls. In the second case (case 2), 
the P2 amplitudes overlapped the amplitudes of the normal 
controls.
The latencies of the N-75 component from all of 
the patients were longer than those of normal subjects 
(Figure 1B).
Case reports
All four cases share typical OMD features, and definitive 
diagnosis was made genetically in the three of four cases. 
We present case 1 as the representative data.
Case 1
Case 1 was a 42-year-old woman who stated that her 
visual acuity has been reduced in both eyes for 10 years. 
Several ophthalmologists, psychiatrists, and physicians in 
other   clinics failed to diagnose her   condition, and she was 
referred to Keio University Hospital for further examination. 
Her   sister and cousin had similar   symptoms –   bilateral 
progressive decrease of vision – and were   diagnosed 
with OMD at other hospitals. Her corrected visual   acuity 
was 20/200 in both eyes. Funduscopy and fluorescein 
angiography were normal (Figure 2). Goldman perimetry 
showed a central scotoma of 5° in both eyes (Figure 3). The 
central fusion flicker frequency was 28.6 Hz in the right 
eye and 29.6 Hz in the left eye (48.2 ± 5.3 Hz: mean ± SD 
as normal range in our laboratory). Her right eye had 
normal color vision, and her left eye had mild atypical 
dyschromatopsia.
The scotopic, bright-flash, photopic, and 30-Hz flicker 
full-field ERGs were normal (Figure 4). However, the 
mfERGs in the central areas were reduced (Figure 3). 
The focal macular ERGs recorded at another clinic were 
clearly reduced in both eyes (Figure 5). A diagnosis of OMD 
was made.
The P2 amplitude was 2.3 µV for the 5′, 4.2 µV for the 
10′, 1.5 µV for the 20′, and 1.3 µV for the 40′ checkerboard 
stimuli of the right eye (Figure 6). For the same stimuli 
for the left eye, the P2 amplitudes were 1.0, 2.3, 1.3, and 
2.8 µV, respectively. The N1 latency was 147.5 ms for the 
5′, 117.5 ms for the 10′, 110.0 ms for the 20′, and 102.5 ms 
for the 40′ checkerboard stimuli in right eye (Figure 1B). 
For the left eye and the same stimuli, the N2 latencies 
were 118.8, 105.0, 101.3, and 100.0 ms, respectively. The 
average P2 amplitude was reduced, and the N1 latency was 
delayed in comparison to our laboratory standard values 
(Figure 1).
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Figure 1 Plot of the A) P2 amplitude and B) n1 latency as a function of the size of the checks of the stimulus for the four patients. The average and the standard error of the 
means of normal subjects are plotted as the black line. The n1 latency was delayed in all eyes, while the P2 amplitude was reduced in all eyes except both eyes in case 2.
Figure  2  Fundus  photograph  (above)  and  fluorescein  angiography  (below)   
of case 1 showing no abnormal findings.Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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Discussion
A delayed N2 latency of the pVEPs is not a specific sign of 
optic neuropathy because it is also found in eyes with retinal 
diseases.6–10 Thus for delayed N2 latencies, the differential 
diagnosis is between optic nerve disease and macular disease. 
There are a number of studies that have examined how macu-
lar diseases affect the pVEPs.6–17 However, the results are not 
all in agreement. In general, the pVEPs are attenuated and 
the latencies are delayed in several macular diseases such as 
age-related macular degeneration,6,10,14,16,17 macular hole,6,12,13 
central serous chorioretinopathy,6,10,11,15,18 branch retinal vein 
occlusions,10 and macular dystrophies.6,8,19
Our findings showed that the pVEPs were decreased in 
three of the four cases, and the latencies were delayed in all 
four cases. We would have predicted that the responses would 
be more altered at more advanced stages of the disease.14,16 
However, Bass et al6 showed a significant delay in the latency 
even in eyes with relative good visual acuity of 0.4 or   better. 
Our case 4 had a visual acuity of 20/30 in the right eye, but 
the pVEPs were delayed even with the larger check size 
Left eye
Right eye
case 2 case 3 case 4
Left eye Right eye
B
A
Figure 3 A) goldman perimetry and multifocal electroretinogram (erg) of case 1. B) Multifocal erg of cases 2, 3, and 4. goldman perimetry revealed relative central 
scotoma of 5° in both eyes. The amplitudes of the multifocal ergs are reduced in the central area in all cases.Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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stimulation. The delayed latency and reduced amplitude 
suggest a major contribution of the central cone pathway 
to the pVEPs.
A relative delay in the N1 latency was observed in all eyes, 
while the P2 amplitude was within normal range in both eyes 
in one case (case 2). Okuno et al5 reported that one of three 
affected family members with OMD had a delayed P-100 
implicit time, whereas two other patients, who were daughters 
of the first patient, had normal implicit times. Thus, younger 
OMD patient may have a relatively intact visual pathway 
function. Okuno et al used a 1° checkerboard pattern, and 
we routinely use four stimulus check sizes in the recording 
of the pVEPs. Thus, the stimulus protocol and laboratory 
settings might be the cause of the discrepancy between their 
results and our results. Unfortunately, they did not report the 
amplitude of any component of the pVEP.
Several investigators7,9,10 have reported that retinal   diseases 
may cause an increase in the pVEP latency, and the increase 
was significantly less for eyes with macular diseases than 
that in eyes with optic neuropathy. Shimada et al10 concluded 
that the pVEPs appear to be more sensitive for optic nerve 
diseases than for macular diseases in patients with similar 
visual acuities.
From another point of view, one may ask what is the 
possibility of the concurrent impairment of optic nerve only 
from reduced responses in pVEP and focal macular ERG. 
We believe that such possibility is low in OMD because 
recently identified responsible gene RP1L1 suggests that 
the pathologic site is retina. However, further investigation 
to compare ERG/pVEP signal ratio in such patients and in 
patients affected solely by macular degeneration matched for 
age and visual acuity is waited.
Optical coherence tomography (OCT) examination of the 
fovea of eyes with OMD showed that the fovea was signifi-
cantly thinner.4,20 Recent study in OCT of OMD patients21–23 
demonstrated a defect of the inner segment–outer segment 
junction of the photoreceptors and of the Verhoeff membrane 
(cone outer segment tips). However, degrees of abnormality 
in the photoreceptor layer varied among patients and some 
OMD patients show normal OCT, which means OCT findings 
are not enough to make definitive diagnosis.
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Figure 5 Focal macular electroretinogram (erg) (above) and oscillatory potentials 
(below) recorded from case 1 (left) and normal subject (right). The focal macular 
ergs from the patient are clearly smaller than the responses from the normal eye. 
These ergs were elicited by 5′, 10′, and 15′ stimulus centered on the fovea. The 
black bars show the stimulus duration (100 ms).
Abbreviations: r, right eye; L, left eye.
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Figure 6 pVePs of case 1 (left) and normal subject (right) elicited by checkerboard 
stimulus. The n1 latency is delayed and the P2 amplitude is reduced in all the responses 
elicited by each checkerboard stimuli. The visual angles of the stimuli are shown in the 
middle. Up arrowheads show n-75 and down arrowheads show P-100.
Abbreviations: r, right eye; L, left eye.
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Figure 4 Full-field electroretinogram (ERG) recorded following ISCEV standard 
protocol.  The  stimuli  are  indicated  by  the  arrowheads.  Scotopic,  bright-flash, 
photopic, and 30-Hz flicker full-field ERGs are normal.Clinical Ophthalmology
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There are some limitations in this study. The number of 
cases was limited and this was a retrospective study without 
proper controls. In addition, from retrospective nature, pVEP 
recordings did not accord with ISCEV standards: different 
electrode position, relative small size, and low-contrast   stimuli. 
Further investigations, using proper stimulus according to 
updated ISCEV standards, are needed to determine whether 
we can differentiate OMD from optic neuritis using pVEP.
In conclusion, we showed reduced amplitudes and   longer 
latencies of the pVEPs in eyes with OMD. It would be   helpful 
to find additional parameters in the differential diagnosis 
of OMD from optic neuritis in addition to focal macular 
ERG, which so far is the only diagnostic test to differentiate 
OMD from amblyopia, optic nerve disease, and nonorganic 
disorders.
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